Mesothelioma News Calithera Biosciences, Inc. Presents Preclinical Data For CB-839… By Mesothelioma News March 18, 2014 March 18, 2014 Mesothelioma News CB-839 is a potent, selective, orally bioavailable glutaminase inhibitor that interferes with tumor metabolism and blocks cancer cell growth and survival. Calithera Biosciences, Inc. Presents Preclinical Data For CB-839… Puerto Rico’s Building Science Experts Share Information about Asbestos & Mesothelioma